<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Clin Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">279</journal-id><journal-id journal-id-type="pmc-domain">brjclinpharm</journal-id><journal-id journal-id-type="publisher-id">bcp</journal-id><journal-title-group><journal-title>British Journal of Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0306-5251</issn><issn pub-type="epub">1365-2125</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2014888</article-id><article-id pub-id-type="pmcid-ver">PMC2014888.1</article-id><article-id pub-id-type="pmcaid">2014888</article-id><article-id pub-id-type="pmcaiid">2014888</article-id><article-id pub-id-type="pmid">10606837</article-id><article-id pub-id-type="doi">10.1046/j.1365-2125.2000.00140.x</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Pharmacokinetic analysis of felodipine&#8211;grapefruit juice interaction based on an irreversible enzyme inhibition model</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Takanaga</surname><given-names initials="H">Hitomi</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ohnishi</surname><given-names initials="A">Ayako</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Matsuo</surname><given-names initials="H">Hirotami</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murakami</surname><given-names initials="H">Hideyasu</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sata</surname><given-names initials="H">Hiroko</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kuroda</surname><given-names initials="K">Ken</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Urae</surname><given-names initials="A">Akinori</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Higuchi</surname><given-names initials="S">Shun</given-names></name><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sawada</surname><given-names initials="Y">Yasufumi</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><aff id="au1"><label>1</label><institution>Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University</institution><addr-line>Fukuoka Prefecture, Japan</addr-line></aff><aff id="au2"><label>2</label><institution>Department of Pharmacy, University of Fukuoka Hospital, Faculty of Medicine, University of Fukuoka</institution><addr-line>Fukuoka Prefecture, Japan</addr-line></aff><aff id="au3"><label>3</label><institution>Kyushu Clinical Pharmacology Research Clinic, Kyushu University</institution><addr-line>Fukuoka Prefecture, Japan</addr-line></aff><aff id="au4"><label>4</label><institution>Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University</institution><addr-line>Fukuoka Prefecture, Japan</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><italic>Correspondence:</italic> Dr Yasufumi Sawada, Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka-shi 812-8582, Japan. Tel.: +81-92-642-6610, Fax: +81-92-642-6614.</corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2000</year></pub-date><volume>49</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">151575</issue-id><fpage>49</fpage><lpage>58</lpage><history><date date-type="received"><day>30</day><month>11</month><year>1998</year></date><date date-type="accepted"><day>02</day><month>9</month><year>1999</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2000</year></date></event><event event-type="pmc-live"><date><day>14</day><month>01</month><year>2008</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-16 02:25:14.873"><day>16</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2000 Blackwell Science Ltd</copyright-statement><copyright-year>2000</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="bcp0049-0049.pdf"/><abstract><sec><title>Aims</title><p>Ingestion of grapefruit juice (GFJ) alters the pharmacokinetics of various orally administered drugs. Quantitative evaluation of this GFJ&#8211;drug interaction is required for the proper clinical management of patients.</p></sec><sec sec-type="methods"><title>Methods</title><p>Using felodipine as a model drug, we constructed a pharmacokinetic model based on irreversible inhibition of intestinal cytochrome P450 3A4 (CYP3A4) by GFJ. We fitted previously publised data [<xref ref-type="bibr" rid="b5">5</xref>, <xref ref-type="bibr" rid="b6">6</xref>] for felodipine ER (extended release formulation) to the ratio of CL<sub>GI,int</sub> before and after grapefruit juice ingestion by nonlinear least-squares regression analysis to estimate the reaction rate constant between GFJ and CYP3A4 (K) and the elimination rate constant of CYP3A4 (<italic>k</italic>).</p></sec><sec><title>Results</title><p>The model gave a turnover rate of CYP3A4 of 0.0849 h<sup>&#8722;1</sup>, corresponding to a half-life of 8.16 h, in agreement with reported values. The AUC-time profiles of felodipine ER in the case of different amounts and schedules of GFJ ingestion were simulated using the parameter values estimated from the model.</p></sec><sec><title>Conclusions</title><p>The modelling leads to the important conclusion that GFJ&#8211;felodipine interaction increases with increasing frequency and amount of GFJ ingestion, and that an interval of 2&#8211;3 days between GFJ intake and felodipine administration is necessary if GFJ&#8211;felodipine interaction is to be avoided.</p></sec></abstract><kwd-group><kwd>felodipine</kwd><kwd>grapefruit juice</kwd><kwd>modelling</kwd><kwd>pharmacokinetics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>